Scientists discover a cause of lupus, possible way to reverse it

Original Article ↗ Hacker News Discussion ↗

New research identifying an immune pathway involving the aryl hydrocarbon receptor (AhR) and type I interferon as a driver of lupus is generating both optimism and caution. Commenters explore how this mechanism might connect to other autoimmune and inflammatory conditions (like psoriasis, ME/CFS, Crohn’s, and allergies), the tangled role of infections, microbiome, and environmental factors, and whether targeted immune modulation could replace today’s broad immunosuppression. Several people share personal experiences with diet, biologic drugs, and diagnostics, while clinicians and researchers warn that, despite promising mechanistic insights, translating such basic science into reliable treatments is slow and complex.

Links to ME/CFS and Long COVID

  • Several commenters wonder if the lupus findings (T‑cell imbalance, AHR pathway, interferon) could illuminate ME/CFS or long COVID.
  • Some say ME/CFS funding has been eclipsed by long COVID; others note major programs (e.g., RECOVER, UCSF initiatives) now include ME/CFS‑like cohorts.
  • Hypotheses raised: persistent viral antigens and immune cell exhaustion as shared roots, but this remains unclear.

Role of AHR in Autoimmunity and Cancer

  • AHR is highlighted as central to the lupus paper and already implicated in psoriasis, MS, rosacea, and possibly IBD.
  • Tapinarof (an AHR agonist) is cited as an unusually effective psoriasis topical with sustained remission; coal tar and some natural compounds may also act via AHR.
  • Multiple comments stress AHR signaling is highly context‑dependent: activation can suppress inflammation but also promote tumor growth and dampen anti‑tumor immunity.

Enthusiasm vs Skepticism About the Lupus Paper

  • Enthusiastic reactions focus on:
    • Identifying a more specific immunologic imbalance (CXCL13+ T‑cell subset, AHR vs type‑I interferon) and a plausible way to “reprogram” pathogenic cells.
  • Skeptical voices:
    • Point out it’s basic science in small cohorts, not a therapy.
    • Note similar “promising” biomarkers (e.g., CXCL13 in RA) have not yet translated clinically.
    • Argue lupus is heterogeneous; this mechanism may fit only a subset of patients.

Autoimmune Disease Mechanisms and Therapies

  • Discussion emphasizes that autoimmunity is complex but not a total “black box”: modern drugs target specific cell types (e.g., CD20+ B cells in MS) or pathways (kinases, interferon, IL‑23, TRM cells).
  • Checkpoint inhibitors in oncology are framed as intentionally loosening immune brakes, often causing autoimmune‑like side effects, illustrating the “cancer vs autoimmunity” trade‑off.

Diet, Microbiome, and Lifestyle Anecdotes

  • Many personal stories:
    • Plant‑heavy or vegan diets sending lupus‑like or psoriasis symptoms into remission.
    • Meat‑heavy/carnivore diets putting arthritis or other autoimmune symptoms into remission.
    • Others report the exact opposite (meat worsens inflammation, plants help).
    • Some attribute improvements to specific eliminations (gluten, nightshades, glyphosate‑exposed grains) or probiotics; others find these ineffective.
  • One strong claim: “all autoimmunity is gut dysfunction,” countered by others who see microbiome as one factor among many.
  • Overall, experiences are highly conflicting and not backed by systematic evidence in the thread; several people explicitly warn against overgeneralizing anecdotal diets.

Allergies, Inflammation, and Mental Health

  • Allergies are discussed as overactive immunity; allergen immunotherapy (gradual exposure) is mentioned.
  • Inflammation is linked to depression via cytokines; an interferon‑treated cancer cohort developing depression is cited.
  • Debate over whether vitamin C or other supplements meaningfully reduce inflammation or depression; commenters disagree and call the evidence modest at best.

Environmental, Genetic, and Other Factors

  • Smoking is noted as a risk factor that roughly doubles lupus/psoriasis risk despite AHR pathways.
  • A “hygiene/clean environment” hypothesis is floated for higher autoimmune/allergy rates in affluent countries.
  • HLA‑B27 and other genes are mentioned as shared risk factors across multiple autoimmune disorders.
  • Some speculate that strong autoimmune traits historically improved survival in pandemics, implying trade‑offs.

Cultural / Media Reactions

  • Numerous references to the TV show House (“It’s never lupus”) and jokes about how this discovery would “break” its plots.
  • Several commenters with lupus or family members affected express cautious hope but remain aware this is early‑stage research.